surgery and patients who had undergone extratemporal surgery, 29, 34 while in others all patients who underwent temporal lobe surgery were considered as a single cohort for purposes of analysis, a potential problem since incomplete resections-more likely to occur with lesionectomies or limited resections-are by themselves a poor prognostic indicator for seizure outcome. 7, 20, 24, 26 Multiple questions need further investigation: 1) What characterizes the patient population in which costly repeat VEEG and MR imaging studies are likely to reveal an identifiable, well-localized, potentially resectable seizure focus? 2) Are there any characteristics that differentiate the patient population with a focus of recurrence that is contiguous to the site of the initial surgery from patients with a distant focus (contralateral or extratemporal) that is less amenable to surgical intervention? 3) How does the prognosis associated with either medical or surgical therapy differ among the various above-mentioned anatomical subgroups of surgical failures, and what then determines an ideal candidate for reoperation?
This article represents a preliminary attempt to address some of these issues.
Methods

Patient Selection
We reviewed cases involving adult patients (≥ 18 years of age) with medically refractory focal epilepsy who underwent resective temporal lobe surgery at The Cleveland Clinic between January 1990 and December 2004, excluding those with high-grade brain tumors and those who had undergone prior brain surgery. We only included in this study patients with recurrent postoperative seizures who underwent a repeat VEEG evaluation in our center and had at least 1 year of subsequent follow-up.
Preoperative Patient Evaluation Protocol
A detailed clinical history was obtained in all patients at their initial outpatient visit to the Cleveland Clinic Epilepsy Center. All patients underwent prolonged (5-7 days) scalp VEEG monitoring during which interictal discharges and ictal patterns were recorded and analyzed. In addition, seizures were captured and their semiology was analyzed. 17 All patients underwent high-resolution brain MR imaging with either a 1.5-T or a 3-T system. Additional investigations included a detailed neuropsychological evaluation and FDG-PET scans. Results of the initial evaluation were all discussed in a multidisciplinary patient management conference where recommendation was made to proceed with a resective surgery, insert a VNS, perform additional studies (such as targeted MR imaging with surface coils and ictal SPECT), or perform an invasive evaluation for further investigation.
Subdural electrodes were implanted 1) to confirm the ictal onset zone if scalp EEG information was either nonlocalizing or inconsistent with other noninvasive investigations; 2) to perform functional mapping preoperatively if the ictal onset zone was thought to be close to eloquent cortex; or 3) whenever a multifocal epileptogenic process was suspected based on multifocal noninvasive EEG or imaging findings.
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Surgery and Pathological Subgroups
Initial temporal lobe resections were classified into 4 subgroups: 1) "standard" ATL, including removal of mesial structures, temporal tip, and parahippocampal and inferior temporal gyri (53 patients); 2) selective amygdalohippocampectomy (5 patients); 3) lesionectomy (4 patients); and 4) "tailored" resections either extending beyond the temporal lobe or involving various portions of the temporal neocortex (6 patients). Typically, an ATL at our institution involves the standard removal of temporal neocortex measuring between 4 and 4.5 cm (dominant temporal lobe) and 5 and 5.5 cm (nondominant temporal lobe) from the anterior temporal fossa along the middle temporal gyrus. The hippocampus is removed as far back as the level of the superior colliculus. For selective amygdalohippocampectomy, both transsylvian and transsulcal approaches are used. In general, approximately 3 cm of hippocampus and parahippocampus is resected, and the amygdala is resected along a line connecting the choroidal point of the temporal horn with the M 1 division of the middle cerebral artery. Tailored resections involved various parts of the temporal neocortex based on the results of invasive EEG recordings. Fifty-four percent of patients had intraoperative electrocorticography, preoperative SDE recordings, or both. Postoperative MR imaging confirmed removal of the mesial temporal structures in the majority of patients. Concern about injuring eloquent language cortex prevented complete resections in 1 of the 4 patients with a lesionectomy and in 2 of the 6 patients with tailored resections.
For the purpose of this study, patients were divided into the following etiological subgroups based on the results of MR imaging and surgical pathology: 1) MTS with abnormal MR imaging findings (28 patients), 2) MTS with normal MR imaging findings (16 patients), 3) MCDs with abnormal MR imaging findings (9 patients), 4) MCDs with normal MR imaging findings (3 patients), 5) low-grade tumors (8 patients), and 6) other pathologies (4 patients).
Postoperative Follow-Up
Timing and frequency of seizure recurrences were obtained from medical record review. As per our postsurgical follow-up protocol, all patients were seen at 6 weeks, 6 months (with a 2-hour outpatient EEG), and 1 year after surgery, and then annually thereafter. Those with recurrent seizures were seen more frequently (every 3-6 months). In between clinic visits, patients were required to report breakthrough seizures. After January 2003, all patient phone calls were entered in the electronic medical records. Prior to that date, paper records of phone or mail contact were kept. When medical records indicated that a seizure occurred between 2 follow-up visits or phone contacts, the date of recurrence was taken as the midpoint of this period. With patients having the follow-up schedule detailed above, the period between documented contacts (visits or phone calls) never exceeded 6 months.
Patients being reevaluated for a second surgery again underwent the same rigorous presurgical evaluation process detailed above, including a repeat discussion during a multidisciplinary patient management conference. In general, we allow a period of at least 12 months of per-sistent, recurrent seizures that fail to respond to repeated antiepileptic medication adjustments before recommending re-initiation of a surgical workup in patients willing to even consider a second operation. The threshold to reinitiate testing is usually higher in patients in whom initial surgery was considered palliative rather than curative, or in those with a known incomplete resection of their original epileptic focus (for example, those with original ictal onset zones that encompassed eloquent cortex and were thus partially spared, or those with bilateral temporal seizures recorded preoperatively on scalp electrodes).
Definition of Outcomes
Three different levels of outcomes were analyzed: 1) identifiable versus nonidentifiable focus of recurrence, 2) contiguous versus noncontiguous focus of recurrence, and 3) seizure free versus not seizure free.
Identifiable Versus Nonidentifiable Focus of Re-
currence. After all the detailed testing discussed above (prolonged VEEG, high-resolution MR imaging, nuclear imaging, and invasive EEG), a focus of recurrence was considered identifiable if a clear hypothesis as to its most likely location was unanimously adopted by the multidisciplinary patient management conference. If all testing failed to provide a consistent hypothesis, then the focus of recurrence was classified as nonidentifiable.
Contiguous Versus Noncontiguous Focus of Recurrence.
A focus of recurrence was considered contiguous to the initial surgical bed if the evaluation detailed above suggested that it was in immediate proximity to the area of initial resection. This specifically included recurrences arising from the ipsilateral residual mesial temporal structures (IMT), from the ipsilateral basal temporal lobe (IBT), or from the posterior edge of the resection (ipsilateral posterior temporal lobe). Recurrences arising from the contralateral temporal lobe or extratemporal regions were considered noncontiguous.
Seizure Free Versus not Seizure Free. After reoperation, patients were classified as seizure free if they had maintained an Engel Class I outcome as of their most recent follow-up.
For patients who were treated medically after failed surgery, eventual seizure freedom was defined as no seizures for at least 1 year preceding the most recent follow-up.
Statistical Methods
Clinical, imaging, pathological, surgical, and EEG data from both the preoperative (baseline) and the postoperative (following seizure recurrence) evaluations were correlated with the 3 outcome end points. The data for each variable were summarized with descriptive statistics prior to modeling. For exploratory purposes, an initial univariate analysis was performed using the Wilcoxon rank-sum, chi-square, and Fisher exact tests. This allowed identification of potential prognostic indicators, which were subsequently tested in a multivariate stepwise logistic regression model to identify independent outcome predictors. Results were considered statistically significant at the 5% level (p = 0.05).
Since the mechanisms of seizure recurrence are likely distinct in patients in whom recurrence occurs following a standard ATL as compared with those who undergo tailored temporal resections, we analyzed predictors of a contiguous focus after stratifying the patients into 2 subgroups: those who underwent a standard ATL versus the rest.
Results
Overall Patient Characteristics
Sixty-eight patients fulfilled all criteria for inclusion, and their cases are analyzed in this paper. They represent 71% of the total number of patients in whom temporal lobectomy failed to provide seizure control during the time period of interest. No significant differences in clinical, imaging, or pathological characteristics existed between the 68 cases analyzed here and the other cases that met our inclusion criteria but could not be analyzed because of insufficient follow-up data. Furthermore, the mean timing of the first seizure recurrence in these 68 patients was 12.8 months (median 5 months, range 3 weeks-103 months), which was not significantly different (p = 0.47) from the time to seizure recurrence in patients in the overall temporal lobectomy cohort who did have late or rare breakthrough seizures (Engel Classes IC and ID) but still achieved lasting seizure remission by last follow-up (mean 15.8 months, median 10 months, range 1-104 months). For all these reasons, we consider the analyses performed in this study to be an adequate representation and sampling of the overall group.
Of 68 patients included in this study, 40 (59%) were female and 38 (56%) had undergone left-sided surgery. The mean patient age at the time of the initial surgery was 32.3 years (range 18-54 years) and the mean duration of epilepsy was 19.2 years (range 1-52 years). Overall follow-up duration ranged from 1 to 18.9 years with a mean of 8.7 years. Figure 1 illustrates the overall patient distribution among the various outcome measures.
Identified Versus Nonidentified Focus
A single seizure focus could not be identified in 24 (35%) of the 68 patients for the following reasons: no seizures were recorded in 44% of these 24 patients, ictal patterns were nonlocalizable in 19%, and noninvasive EEG and imaging data were discordant in the remaining 38%. Table 1 shows the results of univariate analysis identifying potential predictors of the ability to identify a seizure focus. Given that seizures were not recorded in several patients during their repeat VEEG evaluation, we included in this analysis only seizure characteristics that could be ascertained via the patient's history. After multivariate analysis, foci of recurrence were more often identified in patients with seizures occurring at least weekly (OR 12. 
Contiguous Versus Noncontiguous Focus
Seven out of 44 patients with an identifiable focus of recurrence had seizures exclusively arising from the contralateral hemisphere (6 temporal, 1 parietal), while 1 developed newly diagnosed generalized epilepsy and 7 had bitemporal seizures. Of 29 patients with recurrent seizures arising from the hemisphere ipsilateral to the side of surgery, 20 had a contiguous focus. We could not identify any significant predictors of a contiguous focus when we analyzed data from all 44 patients considered as a single group (data not shown). Table 2 shows the results of the univariate subgroup analysis for patients who underwent a standard ATL, while Table 3 illustrates results for the remaining surgeries. Table 4 shows the significant outcome predictors identified subsequently with multivariate analysis. Table 5 illustrates the relative impact of those outcome predictors in our cohort.
Seizure Freedom at Last Follow-Up
Fifteen patients underwent reoperation: 8 patients with a mesial or basal temporal focus underwent removal of any remaining temporal lobe tissue, while in 3 patients with recurrence at the posterior edge of the initial surgery, the resection was extended posteriorly, as guided by invasive EEG recordings. The remaining 4 patients underwent extratemporal resections. Seizure outcomes with reoperation are shown in Fig. 1 . The main reasons for not performing a reoperation in all patients with an identified recurrence focus were patient refusal of more surgery and overlap of epileptogenic zones with eloquent cortex. Table 6 shows the predictors of seizure freedom following reoperation with univariate analysis. There was no correlation with age at seizure onset or surgery, seizure frequency (at baseline or after first surgery), change in seizure semiology from baseline, initial MR imaging findings, use of ictal SPECT, type of original surgery, or epilepsy duration. After multivariate modeling, only the region of recurrence (IBT/IMT versus all others) remained as a significant outcome predictor: seizure freedom was achieved in 75% of patients with recurrences from IBT/IMT versus 0% with recurrences from other sites (p = 0.0031).
Six patients underwent VNS implantation; none of them became seizure free.
A total of 11 patients (16%) became seizure free with medical therapy alone (10 with a nonidentified focus of recurrence and 1 with recurrence from the contralateral temporal lobe). These patients tended to have their initial recurrences in the setting of a known provoking factor (50% of patients with initial recurrences in the context of a physiological stress such as fever or infection and 20% of those who had it with antiepileptic drug withdrawal regained seizure freedom as opposed to 12% of those with no initial trigger, p = 0.12). Patients with a favorable longterm outcome also had later seizure recurrences (mean timing to first seizure in patients eventually regaining seizure freedom was 28.1 months vs 9.7 months in those who continued to experience seizures, p = 0.07).
Discussion
In this paper we attempt to provide a systematic approach to the evaluation of patients with TLE in whom surgery has failed to control seizures.
The first challenge facing the epileptologist caring for a patient with recurrent seizures after TLE surgery is to decide at what point to initiate another presurgical evaluation. That decision is partly influenced by the likelihood of identifying a seizure focus with VEEG and imaging. Our data suggest that seizure frequency and timing of first seizure recurrence are very useful indicators in this regard (Table 1) : an almost 100% yield of a repeat evaluation was seen in patients who had at least 4 seizures per month with recurrences starting within a year of surgery, suggesting that this might be the ideal population for reevaluation. This yield dropped to less than 1 Fig. 1 . Distribution of cohort of patients who experienced seizure recurrence following temporal lobe resection. * Seventeen patients were treated medically, with 10 (59%) becoming seizure free; 1 underwent VNS implantation but continued to experience seizures; and 6 were lost to follow-up. † Three patients underwent VNS implantation (none became seizure free), and only 1 of the remaining 15 eventually became seizure free with medical therapy. in 5 if neither criterion was fulfilled and to about 60% if only 1 was ( Table 7 ), suggesting that it might be advisable to wait and exhaust medical therapy before initiating a second surgical evaluation in this situation. This observation has significant implications when considering the cost-effectiveness of initiating an additional surgical evaluation, and identifies useful characteristics for patient selection prior to embarking on time-consuming and expensive testing. The inefficiency of performing VEEG and detailed imaging in this patient subgroup (rare seizures starting late after surgery) is further underscored by our observation that 10 (42%) of 24 patients with a nonidentifiable seizure focus eventually became seizure free with medical therapy alone. This frequency is comparable to the 32% seizure-free outcome observed by Janszky et al. 9 with medical therapy alone during the 2nd postoperative year after failed TLE surgery in patients who had "rare" seizures in the 1st 6 postoperative months. It also mirrors the close-to-30% likelihood of the "running down" phenomenon after ATL.
6,25 A low postoperative seizure frequency would reduce the chances of capturing a seizure during VEEG evaluation, while later seizure recurrences have been suggested to correlate with milder epilepsy. 10, 18, 31 Our data here confirm prior literature 11, 19 suggesting that breakthrough seizures occurring late after surgery or in the setting of a known potential trigger do not carry the same long-term prognostic significance as other postoperative seizure recurrences, as patients with late breakthrough seizures have a decent chance of regaining seizure freedom. The second factor that might influence candidacy for reoperation is the likelihood that the focus of recurrence is contiguous to the initial surgical bed. Our data suggest that when evaluating this question, it is useful to stratify the patients into those who experience treatment failure following a standard ATL versus those who experience it after other limited or tailored resections. After a standard ATL, 100% of our patients with bitemporal MR imaging abnormalities at baseline and almost 80% of those with contralateral temporal spiking experienced recurrence from a noncontiguous focus, the contralateral temporal lobe (p = 0.04 and p = 0.05, respectively). In a previous report evaluating outcome of TLE surgery in 371 patients, bilateral MR imaging abnormalities reduced the chances of seizure freedom from 78% down to 58% at 2 years, while persistence of spiking 6 months after surgery reduced it from 81% to 65%, 10,14 with contralat- eral temporal spiking being associated with a 5-fold increase in severity of seizure recurrence as measured by seizure frequency. 10 Hennessy et al. 8 found that up to 25% of patients with residual mesial temporal structures after unsuccessful TLE surgery had recurrent seizures exclusively from the contralateral hippocampus, with contralateral hippocampal MR imaging signal changes in threefifths of those cases. So, while this report concurs with several previous studies in finding that recurrences after ATL usually arise from the ipsilateral hemisphere, 8, 20, 26, 29 our data characterize the subgroup of patients who experience recurrence from the contralateral temporal lobe as those showing baseline imaging and/or electrophysiological abnormalities in the contralateral hippocampus.
After limited or tailored temporal lobe resections, a distant focus of recurrence was 12 times more likely in surgical failures manifesting within 6 postoperative months, and 28 times more likely in patients who required SDEs in their initial surgical workup (Table 4) , whereas all patients in whom treatment failure occurred more than 6 months postoperatively and who never had prior SDE evaluations had recurrent seizures from the temporal tissue immediately adjacent to the surgical bed ( Table 5 ). The need to use SDEs has been repeatedly associated with poorer outcomes after ATL. 10, 12, 15, 26 Our results suggest that this might be due to the need for SDEs reflecting a more diffuse or poorly localized epileptogenicity. In our cohort, the prior use of SDEs correlated with 2 variables associated with a distant recurrence on univariate analysis: all patients who lacked the classic temporal 4, 5, 13 automotor semiology postoperatively had required SDEs (as opposed to 45% of those who mainly had automotor seizures, p = 0.01), suggesting an epileptogenicity extending beyond the temporal lobe. Also, all the patients with ipsilateral frontal spiking during their initial VEEG evaluation required invasive EEG monitoring (compared with 50% otherwise, p = 0.03), suggesting that in surgical failures following SDE evaluation to differentiate a frontal from a temporal focus, the recurrence is likely to be extratemporal, specifically frontal.
No previous work has evaluated the correlation between timing and location of seizure recurrence. One hypothesis potentially explaining our results would be the concept of TLE as an epileptogenic network involving the temporal lobe, rather than a single localized focus:
23 when a limited resection interrupts that network, seizures stop for a significant amount of time before recurring (and thus the delayed recurrence in patients with a contiguous focus); yet, when the epileptogenicity is diffuse (as in patients requiring SDEs) or when the resection is remote from the epileptogenic network, seizures continue unabated after surgery. Some evidence supports this hypothesis in isolated studies evaluating outcomes of limited temporal resections. In a series of temporal dysembryoplastic neuroepithelial tumor resections, ATL led to a better seizure outcome (Engel Class I, 83.3%; Engel Class IA, 66.7%) than lesionectomy (Engel Classes I and IA, 33.3%);
3 in another report of surgeries in adults with dual pathology, lesionectomy plus mesial temporal resection resulted in complete seizure freedom in 73% of patients, as opposed to 20% with mesial resection alone and 12.5% with a lesionectomy alone, 16 suggesting that recurrent seizures in surgical failures were arising from neighboring unresected temporal tissue. In one study evaluating outcomes of selective amygdalohippocampectomy, patients in whom surgery had failed and who initially required invasive EEG recording had more evidence of extratemporal MR imaging lesions and did not benefit from extension of the original resection, 1 as opposed to the situations in which equivalent outcomes were achieved with selective amygdalohippocampectomy and ATL when epileptogenicity seemed restricted to the mesial temporal structures. 10, 24, 30, 33 An extratemporal or "temporal plus" epilepsy involving the insula has been proposed as an important reason for treatment failure in patients with early ictal signs and symptoms suggesting initial extratemporal involvement of the perisylvian region, the orbitofrontal cortex, or the temporoparietooccipital junction (as with our group without any automotor semiology after temporal lobe surgery), and in those with suspected TLE but normal MR imaging requiring SDEs (as in our cohort needing SDEs prior to tailored resections). 2, 22, 23 Our overall rate of seizure freedom with reoperation (6 [40%] of 15 cases) mirrors that of prior series of reoperation after failed TLE surgery 7, 20, 26, 29 identifying short epilepsy duration, 29 a reoperation involving the initial surgical bed, 34 focal preoperative interictal discharges, 26,29 a history of febrile seizures or abnormal imaging, 26 and a tumoral etiology 7 as possible favorable prognostic indicators. Similarly, we found that MCD and MTS, as well as semiology suggesting an extratemporal focus, were associated with lower chances of success with reoperation on univariate analysis (Table 6 ). However, our data suggest that it is more useful to consider outcome after reoperation in relation to the site of seizure recurrence: 75% of our patients having a "completion" of their temporal lobe resection for recurrences arising in the ipsilateral mesial or basal temporal regions became seizure free as opposed to none of those with an additional frontal resection or neocortical extension into the posterior quadrant (Fig. 1, Table 6 ). This is concordant with prior reports showing poor outcomes after frontotemporal resections, 27, 29, 34 and with a posterior temporal localization of the recurrence focus. 26 Ideal candidates for reoperation may just be patients with a truly localized mesial TLE with an incompletely resected epileptogenic hippocampus. Patients with an ambiguous epileptogenic focus thought to be temporal on a first SDE evaluation and then frontal on a second SDE evaluation, or those with neocortical epilepsy extending to the posterior quadrant or within the depths of the insula, may present the most challenging surgical cases given our current surgical abilities.
Study Limitations
The main limitation of this study is its retrospective nature. Although it does represent the largest study of fully reevaluated temporal lobectomy surgical failures (with VEEG and imaging), it still suffers from selection biases inherently related to our tertiary care center's specific target population and methods of care. This may limit the generalizability of our findings. Another limitation is the absence of ictal recordings in some patients after surgery. Ideally, our results should be validated in a prospective study.
Conclusions
In patients suffering from recurrent seizures after TLE surgery, the highest chance of identifying a focus of recurrence exists when seizures are frequent (> 4 per month) and start early (< 1 postoperative year). Prior contralateral temporal spiking, early timing of recurrent seizures, and prior need to use invasive EEG recordings highlight patients with a focus of recurrence that is distant to the original resection bed. Predictors of the location of the focus of recurrence, as well as results with reoperation, may provide insights into the mechanisms of surgical failure. Ideal candidates for reoperation are patients with ipsilateral mesial or basal temporal recurrences. Our report is limited by its retrospective nature, and our results need to be validated in larger scale prospective studies.
